Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2081)
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
3,600
Price
$29.50
Total Value
$106.20K
Shares Held After
43,900
% of Holdings
7.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
828
Price
$502.71
Total Value
$416.24K
Shares Held After
19,131
% of Holdings
4.1%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
500
Price
$33.27
Total Value
$16.63K
Shares Held After
27,598
% of Holdings
1.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
6,728
Price
$32.62
Total Value
$219.43K
Shares Held After
28,098
% of Holdings
19.3%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,736
Price
$19.05
Total Value
$33.07K
Shares Held After
80,737
% of Holdings
2.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
853
Price
$80.05
Total Value
$68.28K
Shares Held After
855,073
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
24,147
Price
$79.45
Total Value
$1.92M
Shares Held After
855,926
% of Holdings
2.7%
Boundless Bio, Inc. (BOLD)
ARCH Venture Fund IX, L.P. — 10% Owner
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
CRANDELL KEITH — 10% Owner
Shares
16,000
Price
$2.49
Total Value
$39.84K
Shares Held After
0
% of Holdings
100.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
23,000
Price
$123.59
Total Value
$2.84M
Shares Held After
58,117
% of Holdings
28.4%
Intellia Therapeutics, Inc. (NTLA)
Dube Michael P — VP, Chief Accounting Officer
Shares
2,641
Price
$16.78
Total Value
$44.32K
Shares Held After
66,886
% of Holdings
3.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
600
Price
$317.15
Total Value
$190.29K
Shares Held After
41,514
% of Holdings
1.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
900
Price
$315.78
Total Value
$284.20K
Shares Held After
42,114
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$314.58
Total Value
$31.46K
Shares Held After
43,014
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
700
Price
$313.46
Total Value
$219.42K
Shares Held After
43,114
% of Holdings
1.6%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,081
Price
$312.28
Total Value
$337.57K
Shares Held After
43,814
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,119
Price
$311.72
Total Value
$348.81K
Shares Held After
44,895
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
104
Price
$310.20
Total Value
$32.26K
Shares Held After
46,014
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
396
Price
$308.99
Total Value
$122.36K
Shares Held After
46,118
% of Holdings
0.9%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
12,942
Price
$22.67
Total Value
$293.44K
Shares Held After
411,861
% of Holdings
3.0%
Omada Health, Inc. (OMDA)
Duffy Sean P. — Director
Shares
12,944
Price
$22.70
Total Value
$293.79K
Shares Held After
411,861
% of Holdings
3.0%
Inogen Inc (INGN)
Yi Boyer Jennifer M — EVP Entrprs Enblmnt, Ch HR Off
Shares
10,938
Price
$6.60
Total Value
$72.15K
Shares Held After
5,039
% of Holdings
68.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,175
Price
$89.31
Total Value
$998.03K
Shares Held After
9,755
% of Holdings
53.4%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
2,801
Price
$88.51
Total Value
$247.92K
Shares Held After
20,930
% of Holdings
11.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
11,024
Price
$87.33
Total Value
$962.78K
Shares Held After
23,731
% of Holdings
31.7%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
400
Price
$24.78
Total Value
$9.91K
Shares Held After
21,874
% of Holdings
1.8%
CASTLE BIOSCIENCES INC (CSTL)
Oelschlager Kristen M — Chief Operating Officer
Shares
8,186
Price
$24.40
Total Value
$199.74K
Shares Held After
22,274
% of Holdings
26.9%
Scholar Rock Holding Corp (SRRK)
Gilman Michael — Director
Shares
43
Price
$54.81
Total Value
$2.36K
Shares Held After
59,511
% of Holdings
0.1%
Scholar Rock Holding Corp (SRRK)
Gilman Michael — Director
Shares
1,155
Price
$54.23
Total Value
$62.63K
Shares Held After
59,554
% of Holdings
1.9%
Scholar Rock Holding Corp (SRRK)
Gilman Michael — Director
Shares
1,346
Price
$53.54
Total Value
$72.07K
Shares Held After
60,709
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$24.29
Total Value
$6.75K
Shares Held After
12,368
% of Holdings
2.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,153
Price
$24.29
Total Value
$28.01K
Shares Held After
34,602
% of Holdings
3.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,357
Price
$24.29
Total Value
$32.96K
Shares Held After
40,710
% of Holdings
3.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
6,214
Price
$24.29
Total Value
$150.94K
Shares Held After
21,479
% of Holdings
22.4%
Scholar Rock Holding Corp (SRRK)
Burow Kristina — Director
Shares
948
Price
$54.28
Total Value
$51.46K
Shares Held After
114,657
% of Holdings
0.8%
Scholar Rock Holding Corp (SRRK)
Reed Joshua — Director
Shares
948
Price
$54.28
Total Value
$51.46K
Shares Held After
19,518
% of Holdings
4.6%
Scholar Rock Holding Corp (SRRK)
Burow Kristina — Director
Shares
2,105
Price
$53.49
Total Value
$112.60K
Shares Held After
115,605
% of Holdings
1.8%
Scholar Rock Holding Corp (SRRK)
Reed Joshua — Director
Shares
2,105
Price
$53.50
Total Value
$112.61K
Shares Held After
20,466
% of Holdings
9.3%
Scholar Rock Holding Corp (SRRK)
FLIER JEFFREY S. — Director
Shares
15
Price
$54.88
Total Value
$823.14
Shares Held After
27,856
% of Holdings
0.1%
Scholar Rock Holding Corp (SRRK)
FLIER JEFFREY S. — Director
Shares
1,470
Price
$54.24
Total Value
$79.73K
Shares Held After
27,871
% of Holdings
5.0%
Scholar Rock Holding Corp (SRRK)
FLIER JEFFREY S. — Director
Shares
1,568
Price
$53.53
Total Value
$83.94K
Shares Held After
29,341
% of Holdings
5.1%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Wong Shelly — SVP, FINANCE AND CAO
Shares
1,404
Price
$2.04
Total Value
$2.86K
Shares Held After
88,401
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Peng Katie — Director
Shares
21
Price
$54.96
Total Value
$1.15K
Shares Held After
34,301
% of Holdings
0.1%
Scholar Rock Holding Corp (SRRK)
Peng Katie — Director
Shares
2,437
Price
$54.25
Total Value
$132.21K
Shares Held After
34,322
% of Holdings
6.6%
Scholar Rock Holding Corp (SRRK)
Peng Katie — Director
Shares
2,988
Price
$53.56
Total Value
$160.04K
Shares Held After
36,759
% of Holdings
7.5%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
11,430
Price
$123.58
Total Value
$1.41M
Shares Held After
85,533
% of Holdings
11.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,698
Price
$33.13
Total Value
$155.64K
Shares Held After
100,991
% of Holdings
4.4%
Showing 101–150 of 2081 transactions (page 3 of 42)